Structure-activity relationships in chemically modified coumermycin.
D000179:Acrylates; D000284:Administration, Oral; D000588:Amines / Q000138:chemical synthesis; D000818:Animals; D000900:Anti-Bacterial Agents / Q000032:analysis / Q000097:blood / Q000138:chemical synthesis / Q000378:metabolism / Q000652:urine; D001412:Bacillus subtilis; D001593:Benzyl Compounds / Q000032:analysis; D001770:Blood Bactericidal Activity; D055598:Chemical Phenomena; D002621:Chemistry; D003500:Cyclization; D004285:Dogs; D004755:Enterobacteriaceae; D006900:Hydroxylation; D008745:Methylation; D008826:Microbial Sensitivity Tests; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy; D011549:Pseudomonas; D012995:Solubility; D013057:Spectrum Analysis; D013210:Staphylococcus; D013297:Streptococcus pyogenes; D013329:Structure-Activity Relationship
D000179:Acrylates; D000588:Amines; D000900:Anti-Bacterial Agents; D001593:Benzyl Compounds